XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net income $ 4,364 $ 8,685
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for loan losses 7,350 1,500
Changes in deferred tax asset, net (2,344)  
Share based compensation expense 609 184
Gain on sale of SBA loans (98)  
Loss on sale of other real estate owned 350 344
Amortization of premium on securities, net 184 20
Accretion of fees on derivative instruments (103) (75)
Accretion of SBA Paycheck Protection Program fees (1,817) (12,710)
Depreciation, amortization and accretion (105) 414
Earnings on bank-owned life insurance (391) (276)
Proceeds from sale of loans held for sale   2,345
Changes in operating assets and liabilities:    
Accrued interest receivable and other assets (23,342) (1,100)
Accrued interest payable and other liabilities 20,383 841
Net cash provided by operating activities 5,040 172
Cash flows from investing activities:    
Net increase in interest bearing deposits in other banks   (2)
Increase in non-marketable equity securities (7,687) (3,626)
Investment securities available-for-sale activity:    
Purchases (135,063) (1,000)
Maturities, calls and principal paydowns 766 894
Termination fee proceeds from derivative instruments   945
Net originations on loans held for investment (677,354) 17,290
Net additions to bank premises and equipment (4,951) (1,511)
Proceeds from sales of foreclosed assets 1,326 1,337
Purchase of bank owned life insurance (25,000)  
Net cash (used in) provided by investing activities (847,963) 14,327
Cash flows from financing activities:    
Net increase in deposits 757,244 149,616
Net repayment of FHLB Advances (32,000) (20,000)
Net proceeds from subordinated debt offering 80,319  
Proceeds from (repayment of) notes payable 29,875 (375)
Proceeds from stock options exercised 116 760
Net cash provided by financing activities 836,101 135,713
Change in cash and cash equivalents (6,822) 150,212
Cash and cash equivalents at beginning of period 327,025 203,560
Cash and cash equivalents at end of period 320,203 353,772
Supplemental Disclosures of Cash Flow Information:    
Cash paid for interest 5,101 5,973
Cash paid for income taxes 3,750 6,500
Supplemental Disclosure of Noncash Investing and Financing Activities:    
Right of use lease assets obtained in exchange for operating lease liabilities 13,150  
Net increase in fair value of ESOP-owned shares   (317)
2021 Private Placement Offering    
Cash flows from financing activities:    
Proceeds from issuance of common stock   5,455
ESOP Contributions    
Cash flows from financing activities:    
Proceeds from issuance of common stock $ 547 $ 257